mifepristone has been researched along with palmitic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gremlich, S; Roduit, R; Thorens, B | 1 |
| Lewis, AW; Randel, RD; Weems, CW; Weems, YS | 1 |
| Di, W; Ding, G; Huang, M; Liu, J; Lv, S; Lv, Y; Qi, H; Sheng, Y; Yu, J; Zhou, S | 1 |
3 other study(ies) available for mifepristone and palmitic acid
| Article | Year |
|---|---|
Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids.
Topics: Animals; Dexamethasone; Fatty Acids; Glucose Transporter Type 2; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mifepristone; Monosaccharide Transport Proteins; Palmitic Acid; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1997 |
Effects of prostaglandins E2 and F2alpha (PGE2; PGF2alpha), trilostane, mifepristone, palmitic acid (PA), indomethacin (INDO), ethamoxytriphetol (MER-25), PGE2 + PA, or PGF2alpha + PA on PGE2, PGF2alpha, and progesterone secretion by bovine corpora lutea
Topics: Abortifacient Agents, Steroidal; Animals; Cattle; Corpus Luteum; Dihydrotestosterone; Dinoprost; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Estrogen Antagonists; Ethamoxytriphetol; Female; In Vitro Techniques; Indomethacin; Mifepristone; Oxytocics; Palmitic Acid; Pregnancy; Progesterone; Tocolytic Agents | 2002 |
11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Animals, Newborn; Calcium Signaling; Cardiomyopathies; Diet, High-Fat; Glucose Tolerance Test; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Palmitic Acid; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2018 |